![\"nuotr.\"](\"https:\/\/www.respublika.lt\/lt\/naujienos\/lietuva\/kitos-lietuvos-zinios\/prokuroras-jaruseviciene-padare-didele-turtine-ir-neturtine-zala-valstybei\/images\/ico_camera_white.gif\")
1 nuotr.<\/p>\n 1 nuotr.<\/p>\n
Lina Jaru\u0161evi\u010dien\u0117. Eltos nuotr.<\/p>\n
\u00a0<\/p>\n
G. Plioplys, antradien\u012f prad\u0117j\u0119s savo baigiam\u0105j\u0105 kalb\u0105 Vilniaus miesto apylink\u0117s teisme nagrin\u0117jamoje baud\u017eiamojoje byloje, pa\u017eym\u0117jo, kad teis\u0117saugos surinka informacija rodo, jog \u012fmon\u0117s \u201eProfarma\u201c si\u016blyti greitieji testai es\u0105 nebuvo tinkami ankstyvajai \u017emoni\u0173 diagnostikai d\u0117l COVID-19.<\/p>\n
Nepaisant to, pasak prokuroro, tuometin\u0117 sveikatos apsaugos viceministr\u0117 L. Jaru\u0161evi\u010dien\u0117 es\u0105 veik\u0117 min\u0117tos \u012fmon\u0117s naudai.\u00a0<\/p>\n
\u201eL. Jaru\u0161evi\u010dien\u0117 netur\u0117jo objektyvi\u0173 duomen\u0173 apie produkto (greit\u0173j\u0173 test\u0173 \u2013 ELTA) kain\u0105, tinkamum\u0105\u201c, \u2013 ai\u0161kino valstyb\u0117s kaltintojas.<\/p>\n
Visgi, kaip teig\u0117 prokuroras, greitieji testai i\u0161 \u012fmon\u0117s \u201eProfarma\u201c buvo \u012fsigyti, nepaisant to, jog \u0161i\u0105 produkcij\u0105 galima buvo \u012fgyti pigiau. Anot G. Plioplio, sumok\u0117ta per 4 mln. eur\u0173 daugiau negu buvo galima sumok\u0117ti u\u017e tok\u012f produkt\u0105 kitam tiek\u0117jui.<\/p>\n
Prokuroro teigimu, L. Jaru\u0161evi\u010dien\u0117, teikdama nepagr\u012fstus ir neteis\u0117tus reikalavimus Nacionalin\u0117s visuomen\u0117s sveikatos prie\u017ei\u016bros laboratorijos vadovui d\u0117l COVID-19 test\u0173 pirkimo, padar\u0117 did\u017eiul\u0119 \u017eal\u0105 valstybei.<\/p>\n
\u201eTokiais veiksmais L. Jaru\u0161evi\u010dien\u0117 padar\u0117 didel\u0119 turtin\u0119 ir neturtin\u0119 \u017eal\u0105 valstybei\u201c, \u2013 pabr\u0117\u017e\u0117 G. Plioplys.\u00a0<\/p>\n
Byla teismui perduota 2022 m.<\/p>\n
Prokurat\u016bra baud\u017eiam\u0105j\u0105 byl\u0105 d\u0117l greit\u0173j\u0173 COVID-19 test\u0173 pirkimo teismui perdav\u0117 2022 m. rugpj\u016bt\u012f.<\/p>\n
\u0160ioje byloje teisiama 2018\u20132020 m. sveikatos apsaugos viceministr\u0117s pareigas \u0117jusi L. Jaru\u0161evi\u010dien\u0117.\u00a0<\/p>\n
Prokurat\u016bra tvirtina, kad ikiteisminio tyrimo metu surinkti duomenys leid\u017eia pagr\u012fstai \u012ftarti, jog L. Jaru\u0161evi\u010dien\u0117, piktnaud\u017eiaudama u\u017eimamomis pareigomis, dirbdama sveikatos apsaugos viceministre, nuo 2020 m. kovo galimai teik\u0117 nepagr\u012fstus ir neteis\u0117tus reikalavimus Sveikatos apsaugos ministerijai pavald\u017eios Nacionalin\u0117s visuomen\u0117s sveikatos prie\u017ei\u016bros laboratorijos vadovui ir darbuotojams d\u0117l greit\u0173j\u0173 COVID-19 test\u0173 pirkimo.<\/p>\n
Tyrimas buvo vykdomas d\u0117l i\u0161 bendrov\u0117s \u201eProfarma\u201c \u012fsigyt\u0173 daugiau negu 500 t\u016bkst. greit\u0173j\u0173 serologini\u0173 test\u0173, u\u017e kuriuos sumok\u0117ta daugiau nei 6 mln. eur\u0173.\u00a0Prokurat\u016bra mano, kad L. Jaru\u0161evi\u010dien\u0117 \u0161iai bendrovei suteik\u0117 privilegij\u0173, veikdama jos interesais, valstybei perkant COVID-19 testus, ir taip padar\u0117 \u017eal\u0105 valstybei.<\/p>\n
L. Jaru\u0161evi\u010dien\u0117 kalt\u0117s nepripa\u017e\u012fsta.<\/p>\n
Apeliacinis teismas yra pripa\u017ein\u0119s, kad valstyb\u0117 u\u017e min\u0117tus testus yra permok\u0117jusi kelioms bendrov\u0117ms ir priteis\u0117 valstybei priteisti per 4 mln. eur\u0173.<\/p>\n","protected":false},"excerpt":{"rendered":"1 nuotr. Lina Jaru\u0161evi\u010dien\u0117. Eltos nuotr. \u00a0 \u00a0 G. Plioplys, antradien\u012f prad\u0117j\u0119s savo baigiam\u0105j\u0105 kalb\u0105 Vilniaus miesto apylink\u0117s…\n","protected":false},"author":2,"featured_media":153311,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[13],"tags":[25,30,31,3158,1115,34,35,24,25780,32,33,37,39,36,38,40,23,22,28,29,25779,26,27],"class_list":["post-153310","post","type-post","status-publish","format-standard","has-post-thumbnail","category-lietuva","tag-antrastes","tag-breaking-news","tag-breakingnews","tag-byla","tag-covid-19","tag-featured-news","tag-featurednews","tag-headlines","tag-jaruseviciene","tag-latest-news","tag-latestnews","tag-lietuva","tag-lietuviu","tag-lithuania","tag-lithuanian","tag-lt","tag-naujienos","tag-news","tag-populiariausios-naujienos","tag-populiariausiosnaujienos","tag-testai","tag-top-stories","tag-topstories"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@lt\/116404440537822324","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/lt\/wp-json\/wp\/v2\/posts\/153310","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/lt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/lt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/lt\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/lt\/wp-json\/wp\/v2\/comments?post=153310"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/lt\/wp-json\/wp\/v2\/posts\/153310\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/lt\/wp-json\/wp\/v2\/media\/153311"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/lt\/wp-json\/wp\/v2\/media?parent=153310"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/lt\/wp-json\/wp\/v2\/categories?post=153310"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/lt\/wp-json\/wp\/v2\/tags?post=153310"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}